ScholarIQanswers from OpenAlex
Takeda Oncology
FunderResearch funding and supported work
Takeda Oncology is a funder indexed in ScholarIQ from OpenAlex.
What is known about Takeda Oncology?
ScholarIQrecord summary
company in Cambridge, United States
How many works does Takeda Oncology have?
ScholarIQindexed works
Takeda Oncology has 1,947 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Takeda Oncology?
ScholarIQopenalex
The OpenAlex for Takeda Oncology is on the source record.
What are the most-cited papers on Takeda Oncology?
ScholarIQmost cited works
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
Antonio González-Martı́n, Bhavana Pothuri, Ignace Vergote, René dePont Christensen, Whitney A. Spannuth Graybill, Mansoor R. Mirza, Colleen McCormick, Domenica Lorusso, Paul Hoskins, Gilles Freyer, Klaus Baumann, К. Jardon, Andrés Redondo, Richard G. Moore, Christof Vulsteke, Roisin E. O’Cearbhaill, Bente Lund, Floor Backes, Pilar Barretina-Ginesta, Ashley Haggerty, María Jesús Rubio-Pérez, Mark S. Shahin, Giorgia Mangili, William H. Bradley, Ilan Bruchim, Kaiming Sun, Izabela A. Malinowska, Yong Li, Divya Gupta, Bradley J. Monk
Molecular Biomarkers of Disease Outcomes and Mechanisms of Acquired Resistance to First-Line Osimertinib in Advanced EGFR-Mutant Lung Cancers
Noura J. Choudhury, Antonio Marra, Jane Sze Yin Sui, Jessica Flynn, Soo‐Ryum Yang, Christina J. Falcon, Pier Selenica, Adam J. Schoenfeld, Natasha Rekhtman, Daniel R. Gomez, Michael F. Berger, Marc Ladanyi, Maria E. Arcila, Charles M. Rudin, Gregory J. Riely, Mark G. Kris, Glenn Heller, Jorge S. Reis‐Filho, Helena A. Yu